COVID-19 Outpatient, Phase COVID-I
Topical Antibacterial Agents for Prevention of COVID-19
What is the purpose of this trial?
The primary objective of this study is to determine whether intranasal application of aminoglycoside (Neosporin) increases local nasal innate immune responses compared to placebo control in healthy participants.
- Trial withBill and Melinda Gates Foundation
- Ages18 years - 60 years
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact email@example.com, or call 877.978.8343 for more information.
- Last Updated12/22/2022
- Study HIC#2000032248